PViMS, or the PharmacoVigilance Monitoring System, is a web-based application used to monitor the safety of medicines. The application was developed by the USAID-funded Systems for Improved Access to Pharmaceuticals and Services [SIAPS] program (2011-2018) and is implemented by the USAID-funded Medicines, Technologies, and Pharmaceutical Services [MTaPS] program (2018-2023), both led by Management Sciences for Health (MSH), a global health nonprofit. PViMS is maintained by MSH.
JBRSOFT is responsible for the further curstomization and implementation of the PViMS platform for Bangladesh. We have been re-structuring the entire system following the requirements of the Directorate General of Drug Administration including improvement the ADR/AEFI reporting and monitoring system by implementing PViMS as a national portal to be handed over to DGDA for routine use, assisting DGDA in customization and enhancement of the ADR/AEFI reporting and monitoring system (PViMS), accommodating new and updated reporting forms, and providing support for electronic data management, auto-generated trending of AEs and analysis.
Furthermore, we are working on the live dashboard, which will connect the system to the VigiFlow software in order to exchange required data (in a specific file format) with the WHO-Uppsala Monitoring Centre (UMC). Additionally, an online (live) report entry form with signalization of relevant fields was developed. We are also adding an editable PDF version of the report form, as well as additional tabs for guidance documents, newsletters, and suggestions/contact information. As part of the development, we have developed a few functionalities to store and retrieve information for users to access: training, visit/inspection, meeting information, signal detection, alert, RMP, reports for the Safety cell, DRM (Adverse Drug Reaction Monitoring), TSC (Technical Subcommittee), ADRAC (Adverse Drug Reactions Advisory Committee), National AEFI committee, reports generated for VigiFlow, DGDA regulatory action report, templates for auto-gene.